ICLR

ICON plc
D

ICLR

145.720
USD
-1.33
(-0.90%)
مغلق
حجم التداول
63,450
الربح لكل سهم
14
العائد الربحي
-
P/E
16
حجم السوق
11,579,530,801
أصول ذات صلة
NEOUSD
NEOUSD
-0.02050
(-0.37%)
5.53407 USD
B
BIO
-5.265
(-2.27%)
227.145 USD
C
CRL
-2.385
(-1.57%)
149.490 USD
DGX
DGX
1.130
(0.63%)
180.170 USD
ILMN
ILMN
-1.120
(-1.27%)
87.000 USD
LH
LH
-0.56
(-0.21%)
261.15 USD
MTD
MTD
-33.18
(-2.79%)
1,155.03 USD
N
NEO
-0.33000
(-4.47%)
7.05000 USD
Q
QDEL
-0.990
(-3.31%)
28.910 USD
TMO
TMO
-12.61
(-3.04%)
402.69 USD
WST
WST
-3.240
(-1.44%)
221.810 USD
المزيد
الأخبار المقالات

العنوان: ICON plc

القطاع: Healthcare
الصناعة: Diagnostics & Research
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.